BiotechTube
Gatehouse Bio

Gatehouse Bio

Cambridge, United States· Est.
gatehousebio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.5M

Overview

Gatehouse Bio is an early-stage biotech applying AI to small RNA (sRNA) biology to discover novel therapeutic targets and design precision oligonucleotide drugs. Its core asset is the Code-Breaker™ platform, which aims to decipher complex mRNA::sRNA interactions to develop biomarker-guided therapies. The company is currently in the pre-clinical development stage, seeking research collaborations, business development partners, and investors to advance its lead programs toward human clinical trials.

PulmonaryCardiacNeurologicalAutoimmune

Technology Platform

Code-Breaker™ platform: An AI-powered platform that decodes the landscape of small RNAs (sRNAs) to identify disease-specific signatures and digitally design biomarker-guided precision oligonucleotide therapeutics.

Funding History

1
Total raised:$4.5M
Seed$4.5M

Opportunities

The company operates in the high-growth fields of RNA therapeutics and AI-driven drug discovery, targeting large markets with unmet needs.
Its integrated biomarker-therapeutic platform approach could enable precision targeting and improve clinical success rates, making it attractive for partnerships.

Risk Factors

The company faces high scientific risk in proving its core hypothesis about sRNA codes, platform validation risk, and significant financial risk as a pre-revenue entity dependent on external funding.
Competition from larger biopharma and AI-drug discovery companies is also a concern.

Competitive Landscape

Gatehouse Bio competes in the emerging niche of sRNA-targeted therapies, which is less crowded than siRNA/mRNA but includes other biotechs and academic spin-outs. It also competes broadly in the AI for drug discovery space against well-funded techbio companies and large pharma internal initiatives.

More companies in AI / Machine Learning →More companies in United States →